MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong · Delayed Price · Currency is HKD 1.660
-0.030 (-1.78%)
May 29, 2026, 4:08 PM HKT
HKG:2160 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 57.04 | 50.81 | 47.41 | 36.4 | 31.61 | |
Revenue Growth (YoY) | 12.28% | 7.15% | 30.28% | 15.14% | 98.56% |
Cost of Revenue | 19.98 | 15.51 | 14.99 | 12.89 | 12.93 |
Gross Profit | 37.06 | 35.3 | 32.43 | 23.51 | 18.69 |
Selling, General & Admin | 37.96 | 31.26 | 41.35 | 33.75 | 23.89 |
Research & Development | 14.46 | 21.56 | 33.47 | 32.45 | 23.79 |
Other Operating Expenses | 4.33 | 1.86 | 14.27 | 10.35 | -0.69 |
Operating Expenses | 56.75 | 54.67 | 89.1 | 76.55 | 46.99 |
Operating Income | -19.69 | -19.37 | -56.67 | -53.04 | -28.31 |
Interest Expense | -1.54 | -0.53 | -0.55 | -0.75 | -3.09 |
Interest & Investment Income | 7.1 | 10.67 | 12.2 | 5.6 | 3.89 |
Earnings From Equity Investments | -7.21 | -8.67 | -9.09 | -10.05 | -0.55 |
Currency Exchange Gain (Loss) | -0.09 | 0 | 0.22 | -0.04 | -0.56 |
Other Non Operating Income (Expenses) | -0.07 | -0.03 | -0.03 | -0.03 | -0.04 |
EBT Excluding Unusual Items | -21.5 | -17.93 | -53.92 | -58.31 | -28.66 |
Merger & Restructuring Charges | -0.98 | - | - | - | - |
Gain (Loss) on Sale of Investments | 4.45 | 11.53 | -11.47 | - | - |
Gain (Loss) on Sale of Assets | -0.01 | -0.1 | 0.01 | -0 | -0.09 |
Asset Writedown | - | - | - | -7.12 | - |
Pretax Income | -18.04 | -6.5 | -65.38 | -65.43 | -28.75 |
Income Tax Expense | 0.79 | 0.98 | 1.12 | 0.45 | 0.1 |
Earnings From Continuing Operations | -18.82 | -7.49 | -66.5 | -65.88 | -28.85 |
Minority Interest in Earnings | 0.01 | 0.54 | - | - | - |
Net Income | -18.82 | -6.95 | -66.5 | -65.88 | -28.85 |
Net Income to Common | -18.82 | -6.95 | -66.5 | -65.88 | -28.85 |
Shares Outstanding (Basic) | 492 | 468 | 473 | 473 | 466 |
Shares Outstanding (Diluted) | 492 | 468 | 473 | 473 | 466 |
Shares Change (YoY) | 5.20% | -1.02% | -0.11% | 1.47% | 36.04% |
EPS (Basic) | -0.04 | -0.01 | -0.14 | -0.14 | -0.06 |
EPS (Diluted) | -0.04 | -0.01 | -0.14 | -0.14 | -0.06 |
Free Cash Flow | -38.21 | -37.42 | -33.13 | -33.13 | -38.55 |
Free Cash Flow Per Share | -0.08 | -0.08 | -0.07 | -0.07 | -0.08 |
Gross Margin | 64.97% | 69.48% | 68.39% | 64.59% | 59.11% |
Operating Margin | -34.51% | -38.13% | -119.52% | -145.74% | -89.54% |
Profit Margin | -32.99% | -13.68% | -140.25% | -181.01% | -91.26% |
Free Cash Flow Margin | -66.99% | -73.65% | -69.87% | -91.02% | -121.97% |
EBITDA | -14.34 | -15.28 | -53.21 | -50.44 | -27.39 |
EBITDA Margin | -25.14% | -30.08% | -112.22% | -138.60% | -86.64% |
D&A For EBITDA | 5.35 | 4.09 | 3.46 | 2.6 | 0.92 |
EBIT | -19.69 | -19.37 | -56.67 | -53.04 | -28.31 |
EBIT Margin | -34.51% | -38.13% | -119.52% | -145.74% | -89.54% |